Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reduced Dosing of G-CSF in Chemotherapy-treated Breast Cancer Patients
NCT01658956Phase 2Unknown
- Sponsor
- Institut Jules Bordet
- Start
- Jul 2012
- Primary completion
- Jul 2015
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of filgrastim in febrile neutropenia (FN), sponsored by Institut Jules Bordet. Status: unknown.
02
Drugs
filgrastim
03
Conditions
febrile neutropenia (FN)
Beyond the preview
Go deeper on NCT01658956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01658956.